Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page
- Check6 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check13 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record with an error screen. The added 403 snippet appears at the top and the surrounding study content appears removed, indicating an access issue affecting viewing of the trial information.SummaryDifference19%

- Check55 days agoChange DetectedThe page revision tag was updated to v3.6.6, indicating an administrative update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded a link to the PHOENIX trial website that contains information about the trial and its participating centers. The sponsor attribution and related labeling were updated to list Biogen as sponsor and include a 'Helpful Links Provided by' note.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of v3.6.4, indicating a small administrative update to the ClinicalTrials.gov record.SummaryDifference0.0%

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.